Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)

Closed

Centers for Disease Control - CGH

Description

The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds.This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy.

Who can apply

  • Others

Contact

Emily Dale<br/>dln6@cdc.gov
dln6@cdc.gov

Key dates & funding
  • PostedMar 4, 2021
  • ClosesMay 4, 2021
  • Award floor$0
  • Award ceiling$0
  • Program funding$0
  • Expected awards1
  • CFDA93.067
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro